Acute and chronic wounds have become a significant healthcare problem. Although there is no solid definition for acute and chronic wounds, it is widely accepted that acute wounds progress through the normal stages of healing and show definite progress within four weeks. In contrast, chronic wounds do not progress normally through the stages of healing and do not show evidence of healing within four weeks. A variety of reasons may account for this difference in healing efficiency. Perhaps foremost is the assortment of bacterial and fungal organisms in the wound. For example, methicillin-resistant staphylococcus aureus (MRSA) and multidrug-resistant microbes have become problematic causative agents of facility-acquired infections. They are also major causes of non-healing diabetic and post-surgical wounds. Wound Dx™ quickly identifies pathogens and detects potential antibiotic resistance so that the best course of treatment can be started as soon as possible. Rapid and comprehensive identification of pathogens is especially important in chronic wounds where patients with venous ulcers, diabetic ulcers or pressure ulcers frequently suffer from prolonged failure to heal and may progress to the need for amputation. Correctly identifying the cause of a chronic wound as well as the local and systemic factors that may be contributing to poor wound healing is critical to successful wound treatment. Wound Dx™ offers the most comprehensive examination of the bacterial and fungal organisms found in the acute and chronic wound. Additionally, the combination of Wound Dx™ and Antibiotic Resistance Dx™ can help physicians and facilities to strengthen antibiotic stewardship programs. VolenteDx brings together valuable physician tools for the best in wound diagnostics, limb preservation, avoidance of adverse events and prevention of unnecessary antibiotic prescribing.